mail unicampaniaunicampania webcerca

logo distabif unicampania mob

logo distabif unicampania

Mirko CORTESE

Insegnamento di MOLECULAR MICROBIOLOGY

Corso di laurea magistrale in MOLECULAR BIOTECHNOLOGY

SSD: BIO/19

CFU: 6,00

ORE PER UNITÀ DIDATTICA: 48,00

Periodo di Erogazione: Primo Semestre

Italiano

Lingua insegnamento

INGLESE

Contenuti

Virologia molecolare; ciclo replicativo virale; Coronaviridae e SARS-CoV-2; organelli replicativi virali; Antivirali; interazione ospite-microrganismo; Quorum sensing; vaccini

Testi di riferimento

Materiale didattico fornito dal docente

Obiettivi formativi

L´obiettivo del corso é di fornire una visione dettagliata della microbiologia molecolare applicata alla salute umana. Verranno illustrati i recenti avanzamenti scientifici nello sviluppo di antivirali e vaccini utilizzando recenti tecniche di biotecnologia

Prerequisiti

Conoscenze di base acquisite durante il percorso di studi triennale in biotecnologia o equivalenti

Metodi didattici

Lezione frontale e seminari

Modalità di verifica dell'apprendimento

Esame orale

English

Teaching language

English

Contents

Molecular virology, viral replication cycle, SARS-CoV-2. Interaction between bacterial and viral pathogens with animal cells and tissues. Quorum sensing. Antivirals and vaccines.

Textbook and course materials

Scientific research articles and reviews provided by the lecturer

Course objectives

The objective of this course is to provide an overview of cellular microbiology applied to human health. Moreover, the course will give an overview of recent advances in development of antivirals and vaccines to prevent bacterial and viral diseases.

Prerequisites

Knowledge acquired with a Bachelor degree in Biotechnology or in Biology, or equivalent academic degrees.

Teaching methods

Frontal lessons and seminars

Assessment methods

Verification of learning consist in an oral exam.

Detailed syllabus

FIRST PART
Molecular virology, viruses classification, methods in virology. Viral replication cycle, positive-strand RNA viruses, Coronaviridae and SARS-CoV-2. Host-virus interactions. Imaging of viruses, electron microscopy

SECOND PART
Cross-talk among microbial cells: quorum sensing in Gram+ and Gram-. Microbial pathogenesis:
development of multidrug resistance, efflux pumps in pathogenic mycobacteria.

THIRD PART
Development and discovery of therapeutics. Antivirals and monoclonal antibodies. Vaccines: correlate of protection, immune response to vaccine. History of vaccine development: inactivated and attenuated vaccines, glycoconjugate vaccines, reverse vaccinology, structural vaccinology. Novel technologies: vectored vaccines, mRNA vaccines, SARS-CoV-2 vaccines.

facebook logoinstagram buttonyoutube logotype